Larvol Delta - CPMGC01802-A-Study-of-MGC018-in-Combination-With-MGD019-in-Participants-With-Advanced-Solid-Tumors

lorigerlimab (MGD019) - MacroGenics

vobramitamab duocarmazine (MGC018) - MacroGenics

http://clinicaltrials.gov/ct2/show/NCT05293496

Nov 20, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next